Clinical Trials in California

Showing 7961-7980 of 8,631 trials

A Pharmacokinetics (PK) Study in Lice Infested Children 6 Months to 3 Years of Age

NCT00988533

The purpose of this study is to determine the bioavailability of 0.5% ivermectin cream in a pediatric population aged 6 months to 3 years.

Head Lice

Topaz Pharmaceuticals Inc30 participantsStarted Sep 2009

Bentonville, Arkansas, United States • Dinuba, California, United States • Los Angeles, California, United States +2 more locations

COMPLETEDPhase 334 miles

A Safety and Efficacy Study Comparing 0.5% Ivermectin Cream to a Vehicle Control in Subjects With Head Lice Infestation

NCT01066585

The purpose of this study is to determine if 0.5% Ivermectin Cream is a safe and effective treatment for head lice infestations.

Head Lice

Topaz Pharmaceuticals Inc410 participantsStarted Mar 2010

Yuma, Arizona, United States • Dinuba, California, United States • Plantation, Florida, United States +5 more locations

COMPLETEDPhase 391 miles

Study to Assess Efficacy of Tacrolimus + Methotrexate Versus Placebo + Methotrexate in Treatment of Rheumatoid Arthritis

NCT00036153

The purpose of this study is to evaluate the efficacy of the combination of tacrolimus + methotrexate compared to methotrexate alone in the treatment of the signs and symptoms of rheumatoid arthritis over 6 months in patients with partial response to methotrexate.

Rheumatoid Arthritis

Astellas Pharma Inc210 participantsStarted Mar 2002

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Scottsdale, Arizona, United States +42 more locations

A Pharmacokinetics (PK) Study in Lice Infested Children 6 Months to 3 Years of Age

A Safety and Efficacy Study Comparing 0.5% Ivermectin Cream to a Vehicle Control in Subjects With Head Lice Infestation

Study to Assess Efficacy of Tacrolimus + Methotrexate Versus Placebo + Methotrexate in Treatment of Rheumatoid Arthritis

Find Trials by Condition in California

Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk Program

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder (DVS 3364)

Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis

Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients

Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors

Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions

EPO906 Therapy in Patients With Advanced Kidney Cancer

Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection

AZD7268 Safety and Tolerability Study

Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients

The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive Disorder

Use of Cold and Compression Therapy With Total Knee Replacement Patients

Study of Urgent PC Versus Sham Effectiveness in Treatment of Overactive Bladder Symptoms

Efficacy and Safety Study of Seroquel SR in the Treatment of Generalised Anxiety Disorder

A Study to Determine the Safety, Tolerability and Efficacy of KP-413 in Subjects With Atopic Dermatitis(AD)

Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor

Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis